Inflammatory bowel disease among patients with psoriasis treated with ixekizumab: A presentation of adjudicated data from an integrated database of 7 randomized controlled and uncontrolled trials

Background Inflammatory bowel disease (IBD) occurs more frequently in patients with psoriasis. The 2 diseases have significant genetic overlap, but the pathogenesis underlying their co-occurrence is unknown. Objective We sought to report adjudicated IBD cases (Crohn's disease [CD] and ulcerativ...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of the American Academy of Dermatology 2017-03, Vol.76 (3), p.441-448.e2
Hauptverfasser:	Reich, Kristian, MD, Leonardi, Craig, MD, PC, Langley, Richard G., MD, FRCPC, Warren, Richard B., MBChB (Hons), PhD, Bachelez, Hervé, MD, PhD, Romiti, Ricardo, MD, Ohtsuki, Mamitaro, MD, PhD, Xu, Wen, PhD, Acharya, Nayan, MBBS, MRCP, MFPM, Solotkin, Kathleen, MSN, Colombel, Jean-Frederic, MD, Hardin, Dana S., MD
Format:	Artikel
Sprache:	eng
Schlagworte:	Adolescent Adult Aged Aged, 80 and over Antibodies, Monoclonal, Humanized - adverse effects biologic therapy Colitis, Ulcerative - chemically induced Colitis, Ulcerative - epidemiology Crohn Disease - chemically induced Crohn Disease - epidemiology Crohn's disease Databases, Factual Dermatologic Agents - adverse effects Dermatology Female Humans Incidence Induction Chemotherapy - adverse effects inflammatory bowel disease interleukin-17 antagonists ixekizumab Maintenance Chemotherapy - adverse effects Male Middle Aged psoriasis Psoriasis - drug therapy Randomized Controlled Trials as Topic ulcerative colitis Young Adult
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!